Source link : https://www.newshealth.biz/health-news/low-dose-sglt2-inhibitor-may-protect-kidneys-in-youth-with-t1d/
ORLANDO — Adding a low dose of an SGLT2 inhibitor to insulin improved renal function and glycemic control in adolescents with type 1 diabetes (T1D), the late-breaking ATTEMPT trial found. In the 98-patient study, treatment with a 5-mg dose of oral dapagliflozin (Farxiga) showed a renal-protective effect versus placebo, leading to a significant attenuation in […]
Author : News Health
Publish date : 2024-06-25 18:53:14
Copyright for syndicated content belongs to the linked Source.
Categories